Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.85 USD
+0.06 (2.26%)
Updated Sep 9, 2024 03:58 PM ET
After-Market: $2.87 +0.03 (0.88%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.77 |
EPS Last Quarter | 0.78 |
Last EPS Surprise | -38.58% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.70 |
Next Year | 0.12 |
EPS (TTM) | -5.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.40M | 1.45M | 5.41M | 6.55M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 1.40M | 1.45M | 5.41M | 6.55M |
Low Estimate | 1.40M | 1.45M | 5.41M | 6.55M |
Year ago Sales | 1.60M | 1.17M | 5.66M | 5.41M |
Year over Year Growth Est. | -12.63% | 23.68% | -4.57% | 21.22% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.77 | -0.50 | -1.70 | 0.12 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.77 | -0.50 | -1.70 | 0.12 |
High Estimate | -0.77 | -0.50 | -1.70 | 0.12 |
Low Estimate | -0.77 | -0.50 | -1.70 | 0.12 |
Year ago EPS | -1.83 | -2.48 | -11.02 | -1.70 |
Year over Year Growth Est. | 57.92% | 79.84% | 84.57% | 107.06% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.77 | -0.50 | -1.70 | 0.12 |
7 Days Ago | -0.77 | -0.50 | -1.70 | 0.12 |
30 Days Ago | -1.03 | -0.74 | -2.29 | -0.43 |
60 Days Ago | -1.03 | -0.74 | -2.29 | -0.43 |
90 Days Ago | -1.03 | -0.74 | -2.29 | -0.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.77 | -0.50 | -1.70 | 0.12 |
Zacks Consensus Estimate | -0.77 | -0.50 | -1.70 | 0.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.78 | -1.78 | -2.48 | -1.83 | NA |
Estimate | 1.27 | -2.52 | -2.68 | -2.67 | NA |
Difference | -0.49 | 0.74 | 0.20 | 0.84 | 0.32 |
Surprise | -38.58% | 29.37% | 7.46% | 31.46% | 7.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more